Shasha Liu
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Dihydromyricetin Ameliorates Myocardial Ischemia-Reperfusion Injury by Modulating CKLF1-Mediated Cardiomyocyte Pyroptosis.
Journal: Phytotherapy research : PTR
Published: October 13, 2025
Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical.
Journal: Metabolism: clinical and experimental
Published: April 23, 2025
Ginsenoside Rg1 controls CKLF1-mediated apoptosis to reduce hypoxic/reoxygenation injury in HT22 cells.
Journal: Frontiers in pharmacology
Published: November 15, 2024
Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 29, 2024
Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases.
Journal: Ageing research reviews
Published: July 26, 2024
A peripheral system disease-Pulmonary hypertension.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 10, 2024
Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases.
Journal: Phytotherapy research : PTR
Published: January 01, 2024
Ginsenoside Rg1 treats ischemic stroke by regulating CKLF1/CCR5 axis-induced neuronal cell pyroptosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 24, 2023
CC chemokines Modulate Immune responses in Pulmonary Hypertension.
Journal: Journal of advanced research
Published: August 08, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026